Related Experiment Video
Updated: Jun 6, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Prospective study of renal function in HIV-infected pediatric patients receiving tenofovir-containing HAART regimens
Pere Soler-Palacín1, Susana Melendo, Antoni Noguera-Julian
1Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron University Hospital, Spain. psoler@vhebron.net
Insights
Tenofovir disoproxil fumarate (TDF) use in HIV-infected children is associated with renal tubular dysfunction, including abnormal urine osmolality, decreased phosphate absorption, and proteinuria. Regular monitoring of kidney tubular function is recommended for these pediatric patients.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- Pharmacology
Background:
- Tenofovir disoproxil fumarate (TDF) is a key antiretroviral medication used in managing HIV infection.
- Understanding the long-term renal effects of TDF in pediatric populations is crucial for patient management.
- Previous studies have indicated potential renal toxicity associated with TDF, necessitating further investigation in children.
Purpose of the Study:
- To evaluate the impact of tenofovir disoproxil fumarate (TDF) on renal function in HIV-infected pediatric patients.
- To identify specific markers of renal dysfunction associated with TDF use in this cohort.
- To provide evidence-based recommendations for monitoring renal health in children on TDF therapy.
Main Methods:
- A prospective, multicenter study involving HIV-infected pediatric patients (≤18 years) receiving TDF for at least 6 months.
- Renal function was assessed through urine and serum analyses, including creatinine clearance, urine osmolality, phosphate, and potassium levels.
- Data analysis focused on changes in renal parameters after a minimum of 6 months of TDF treatment.
Main Results:
- No significant changes in estimated creatinine clearance were observed in the 40 participating pediatric patients.
- Abnormalities in renal tubular function were noted, including abnormal urine osmolality (8/37), decreased tubular phosphate absorption (28/38), and proteinuria (33/37).
- Statistically significant decreases in serum phosphate and potassium levels were observed during TDF treatment, with a negative correlation between phosphate concentration and duration of TDF therapy.
Conclusions:
- Tenofovir disoproxil fumarate (TDF) use is significantly associated with renal tubular dysfunction in HIV-infected pediatric patients.
- The findings highlight the importance of assessing tubular function, not just glomerular function, in children on TDF.
- Periodic monitoring of renal tubular function is recommended for HIV-infected pediatric patients receiving TDF to mitigate potential adverse effects.
Aim:
to describe the impact of tenofovir disoproxil fumarate (TDF) use on renal function in HIV-infected pediatric patients.
Design:
it is a prospective, multicenter study. The setting consisted of five third-level pediatric hospitals in Spain. The study was conducted on patients aged 18 years and younger who had received TDF for at least 6 months. The intervention was based on the study of renal function parameters by urine and serum analyses. The main outcome measures were renal function results following at least 6 months of TDF therapy.
Results:
forty patients were included (32 were white and 26 were diagnosed with AIDS). Median (range) duration of TDF treatment was 77 months (16-143). There were no significant changes in the estimated creatinine clearance. Urine osmolality was abnormal in eight of 37 patients, a decrease in tubular phosphate absorption was documented in 28 of 38 patients, and 33 of 37 patients had proteinuria. A statistically significant decrease in serum phosphate and potassium concentrations was observed during treatment (P = 0.005 and P = 0.003, respectively), as well as a significant relationship between final phosphate concentration and tubular phosphate absorption (P = 0.010). A negative correlation was found between phosphate concentration and time on TDF.
Conclusions:
TDF use showed a significant association with renal tubular dysfunction in HIV-infected pediatric patients. Periodic assessment of tubular function may be advisable in the follow-up of this population.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Serum Studies: Renal Function Tests
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

